{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:21:59Z","timestamp":1761128519196},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.ijantimicag.2006.08.025","type":"journal-article","created":{"date-parts":[[2006,11,29]],"date-time":"2006-11-29T22:25:15Z","timestamp":1164839115000},"page":"79-83","source":"Crossref","is-referenced-by-count":10,"title":["Effect of antifungal treatment in a murine model of blastoschizomycosis"],"prefix":"10.1016","volume":"29","author":[{"given":"Carolina","family":"Serena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00e7al","family":"Marin\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Marimon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Guarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2006.08.025_bib1","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/clinids\/12.4.570","article-title":"Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients","volume":"12","author":"Martino","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib2","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1128\/JCM.43.4.1818-1828.2005","article-title":"Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature","volume":"43","author":"Girmenia","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1086\/380643","article-title":"Blastoschizomyces capitatus infection in patients with leukemia: report of 26 cases","volume":"38","author":"Martino","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1470-9465.2004.00842.x","article-title":"Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp","volume":"10","author":"Bouza","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1469-0691.2001.tb00005.x","article-title":"Uncommon opportunistic fungi: new nosocomial threats","volume":"7","author":"Groll","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib6","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1128\/AAC.47.12.3985-3988.2003","article-title":"In vitro susceptibility testing of Geotrichum capitatum: comparison of the E-test, disk diffusion, and Sensititre colorimetric methods with the NCCLS M27-A2 broth microdilution reference method","volume":"47","author":"Girmenia","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/JCM.34.3.753-755.1996","article-title":"Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients","volume":"34","author":"D\u2019Antonio","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/JCM.36.1.198-202.1998","article-title":"In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens","volume":"26","author":"Espinel-Ingroff","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib9","unstructured":"National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. 2nd ed. Approved standard M27-A2. Wayne, PA: NCCLS; 2002."},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib10","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1128\/AAC.42.10.2467","article-title":"Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression","volume":"42","author":"Graybill","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1128\/AAC.39.4.924","article-title":"Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice","volume":"39","author":"Graybill","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1054\/drup.2000.0171","article-title":"The role of murine models in the development of antifungal therapy for systemic mycoses","volume":"3","author":"Graybill","year":"2000","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1201-9712(03)90037-3","article-title":"Newer antifungal therapy for emerging fungal pathogens","volume":"7","author":"Steinbach","year":"2003","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1124\/dmd.31.6.731","article-title":"The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human","volume":"31","author":"Roffey","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1128\/AAC.45.2.601-604.2001","article-title":"Efficacy of voriconazole in treatment of murine pulmonary blastomycosis","volume":"45","author":"Sugar","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib16","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1128\/AAC.47.12.3976-3978.2003","article-title":"Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice","volume":"47","author":"Capilla","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib17","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/jac\/dkg261","article-title":"Improving the mouse model for studying the efficacy of voriconazole","volume":"51","author":"Graybill","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib18","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1128\/AAC.49.12.4867-4875.2005","article-title":"Comparative efficacies of conventional amphotericin B, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis","volume":"49","author":"Clemons","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.08.025_bib19","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1128\/AAC.43.9.2116","article-title":"Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model","volume":"43","author":"Andes","year":"1999","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857906003827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857906003827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T04:22:30Z","timestamp":1587270150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857906003827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0924857906003827"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2006.08.025","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}